Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options
Open Access
- 1 September 2006
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 108 (5) , 1451-1460
- https://doi.org/10.1182/blood-2006-02-005017
Abstract
The recent literature shows that interest in ocular adnexal lymphomas and their biologic and clinical characteristics—along with their possible association with Chlamydia psittaci infection and therapeutic management with rituximab or anti-Chlamydia psittaci antibiotic therapy—is considerable. These new data have modified the previously reported features of this disease and have made an updated review of the literature necessary. The aims of this review are to present the current knowledge on the biology of these lymphomas, their clinical features and prognostic factors, and the panel of all available treatment options.Keywords
This publication has 101 references indexed in Scilit:
- Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patientsBritish Journal of Haematology, 2006
- T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphomaLeukemia, 2005
- Anti‐CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctivaEuropean Journal of Haematology, 2004
- Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical OutcomeJournal of Clinical Oncology, 2003
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003
- A case of Sjoegren's syndrome with marked lacrimal gland enlargement, atypical onset and IgA-M-proteinemia.Japanese Journal of Clinical Immunology, 2002
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy & Radiopharmaceuticals, 1997
- CD20: a regulator of cell-cycle progression of B lymphocytesImmunology Today, 1994
- Radiotherapy is successful treatment for orbital lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 1993